Biopsy Devices Market 2017 by Product, Application, Guidance & by End User - Global Forecast to 2022
DUBLIN, September 8, 2017 /PRNewswire/ --
The "Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022" report has been added to Research and Markets' offering.
The global biopsy devices market is projected to reach USD 2.42 Billion by 2022 from USD 1.74 Billion in 2017, growing at a CAGR of 6.8% during the forecast period
Factors such as increasing cancer prevalence, the shift towards minimally invasive surgeries, growing government & global health organizations initiatives to spread awareness about cancer, and the improved reimbursement scenario in U.S. are boosting the growth of global market.
The report analyzes the global biopsy devices market by product, guidance technique, application, end user, and region. Based on product, the global market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products (forceps, markers, probes, punches, curettes, and sutures). In 2016, the needle-based biopsy instruments segment accounted for the largest share of global market mainly due to the increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.
North America holds the largest share of this market. However, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the rising prevalence of cancer, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending and government initiatives, and rising focus of key market players in the region are driving the growth of market in Asia-Pacific.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Biopsy Devices: Market Overview
4.2 Biopsy Devices Market: Developed vs Developing Countries
4.3 Geographic Snapshot: Biopsy Devices Market (2016)
4.4 Biopsy Devices Market, By Product (2017 vs 2022)
4.5 Biopsy Devices Market : Geographic Mix
5 Market Overview
5.1 Key Market Dynamics
5.1.1 Market Drivers
5.1.1.1 Rising Prevalence of Cancer
5.1.1.2 Increasing Preference for Minimally Invasive Surgeries
5.1.1.3 Initiatives Undertaken By Government and Global Health Organizations
5.1.1.4 Improved Reimbursement Scenario in U.S.
5.1.2 Market Restraints
5.1.2.1 Product Recalls
5.1.2.2 Risk of Infections
5.1.3 Market Opportunities
5.1.3.1 Emerging Economies
5.1.4 Market Challenges
5.1.4.1 Underdeveloped Healthcare Infrastructure and Dearth of Resources in Developing Countries
5.2 Industry Trends
5.2.1 Emergence of Liquid Biopsy
5.2.2 Development of Fully Integrated Biopsy Devices
5.3 Regulatory Analysis
6 Global Biopsy Devices Market, By Product
6.1 Introduction
6.2 Needle-Based Biopsy Instruments
6.2.1 Core Biopsy Devices
6.2.2 Aspiration Biopsy Needles
6.2.3 Vacuum-Assisted Biopsy Devices
6.3 Procedure Trays
6.4 Localization Wires
6.5 Other Products
7 Global Biopsy Devices Market, By Application
7.1 Introduction
7.2 Breast Biopsy
7.3 Lung Biopsy
7.4 Colorectal Biopsy
7.5 Prostate Biopsy
7.6 Other Applications
8 Global Biopsy Devices Market, By Guidance Technique
8.1 Introduction
8.2 Ultrasound-Guided Biopsy
8.3 Stereotactic-Guided Biopsy
8.4 Mri-Guided Biopsy
8.5 Other Guidance Techniques
9 Global Biopsy Devices Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Academic and Research Institutes
9.4 Diagnostic and Imaging Centers
10 Biopsy Devices Market, By Region
11 Competitive Landscape
12 Company Profiles
- Argon Medical Devices, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cardinal Health, Inc.
- Cook Group Incorporated
- Devicor Medical Products, Inc. (A Part of Leica Biosystems)
- Fujifilm Holdings Corporation
- Inrad, Inc.
- Medtronic PLC
- Olympus Corporation
For more information about this report visit https://www.researchandmarkets.com/research/7m8zxz/biopsy_devices
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article